Cooperative Agreement U01DP006934
Award Date 9/30/26
Completion Date 9/29/30
Dollars Obligated $500K
Funding Federal Agency
Awarding Federal Agency
Federal Grant Program
Assistance Type
Cooperative Agreement
Place of Performance
Cleveland, OH, USA
Similar Awards
- The Centers for Disease Control and Prevention awarded a $418,550 Cooperative Agreement to Massachusetts General Hospital on September 30, 2026, to advance understanding of pediatric epilepsy incidence and risk factors through a multilevel population health approach under the CDC Investigations and Technical Assistance program (CFDA 93.283). The award funds research activity performed at MGH's Research Management Division in Boston, Massachusetts, with a period of performance extending through...
- The Centers for Disease Control and Prevention awarded National Opinion Research Center a $443,851 cooperative agreement on September 30, 2026, under the CDC Investigations and Technical Assistance program (CFDA 93.283) to conduct epilepsy incidence research among children in the United States. The award funds survey research and data collection activities performed in Chicago, Illinois, over a four-year period ending September 29, 2030. National Opinion Research Center, operating as Norc, is...
- Federal Grant Award Summary Case Western Reserve University (CWRU) received a Project Grant award of $442,750 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853), effective August 1, 2025, through July 31, 2027. The research focuses on elucidating the role of CCPG1, an endoplasmic reticulum (ER)-phagy receptor, in maintaining proteostasis of gamma-aminobutyric acid...
- The National Institute of Allergy and Infectious Diseases awarded Case Western Reserve University $235,500 on April 17, 2026, under the Allergy and Infectious Diseases Research program (CFDA 93.855) to investigate plasma cell-free hemoglobin and red blood cell-derived extracellular vesicles as drivers of cardiovascular disease risk in people with HIV. The research addresses a gap in understanding why HIV-positive individuals face a twofold higher cardiovascular disease risk despite effective...
- The Defense Health Agency awarded Case Western Reserve University $1,399,977 on August 1, 2026, under the Military Medical Research and Development program (CFDA 12.420) to conduct targeted radiopharmaceutical therapy of liver cancer with alpha-particle treatment. The award funds research through July 31, 2029, with place of performance in Cleveland, Ohio. Case Western Reserve University's Office of Research Administration, operating in affiliation with University Hospitals of Cleveland,...
- The National Institute of Neurological Disorders and Stroke awarded Case Western Reserve University $109,412 on January 1, 2026, under the Extramural Research Programs in the Neurosciences and Neurological Disorders program (CFDA 93.853) to evaluate the protein homeostasis of N-methyl-D-aspartate receptors containing pathogenic GluN2B subunits. The research elucidates the proteostasis network regulating NMDA receptor folding, assembly, trafficking, and degradation, with emphasis on how...
- The Department of Health and Human Services Centers for Disease Control and Prevention awarded a cooperative agreement totaling $497,921 to The Children's Hospital of Philadelphia on September 30, 2026, under the Centers for Disease Control and Prevention Investigations and Technical Assistance program (CFDA 93.283). The award funds innovations in elucidating the epidemiology of childhood epilepsy using PEDSnet, a national pediatric learning system. Work is performed in Philadelphia,...
- The National Institute of Neurological Disorders and Stroke (NINDS), part of the Department of Health and Human Services National Institutes of Health, awarded Case Western Reserve University $189,000 on July 20, 2026, under the Drug Use and Addiction Research Programs (CFDA 93.279). Case Western Reserve University, through its Office of Research Administration in affiliation with University Hospitals of Cleveland, will conduct a randomized, sham-controlled, parallel-group feasibility trial...
- The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded Case Western Reserve University's Office of Research Administration Division, doing business as University Hospitals of Cleveland, a $1,467,210 Project Grant on September 30, 2024. The grant supports research to develop a novel dendritic cell therapy approach for mucosal melanoma, focusing on targeting a differentiation epitope in CD11b of tumor-associated inflammatory monocytes. The research aims...
- The National Institute of General Medical Sciences awarded Case Western Reserve University $349,017 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859, Assistance Listing designation R35GM165496) to investigate mechanisms by which microbial metabolites signal to chromatin and regulate gene expression and cellular differentiation. The research centers on microbiota-dependent histone modifications—specifically histone butyrylation and...